The product Xolair has a history that goes back several decades. It was originally approved in 2003 for the treatment of moderate to severe asthma. The drug was subsequently granted marketing ...
CHICAGO (WGN) — For decades, asthma patients have used a drug ... The most common side effects of Xolair are injection site reactions and fever, but the FDA noted that the drug has also been ...
The injection has been shown to minimize reactions ... Xolair has already been FDA-approved to treat asthma. Xolair Xolair is ...
Omalizumab is generally well tolerated in adults and children with allergic asthma. Adverse events most commonly observed are injection-site reaction, viral infection, upper-respiratory-tract ...
The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company ... in the US and EU as a subcutaneous injection lasting a few minutes, instead ...
Britain’s National Institute for Health and Clinical Excellence (NICE) has decided to withdraw its recommendation for asthma drug, Xolair, citing that a review of up-to-date clinical trial data ...